Peter N. Reikes's most recent trade in Ionis Pharmaceuticals Inc was a trade of 3,399 Restricted Stock Unit done . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharma Inc | Peter N. Reikes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 3,399 | 3,399 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Peter N. Reikes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 10,753 | 10,753 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Peter N. Reikes | Director | 15 Oct 2021 | 1,777 | 14,222 (0%) | 0% | 0 | Common Stock | ||
| Ionis Pharma Inc | Peter N. Reikes | Director | 15 Oct 2021 | 1,777 | 10,664 | - | - | Restricted Stock Unit |